Pancreatic Cancer Research

ResearcherGoethe University FrankfurtActive in the last 2 years

Thorsten Oliver Goetze

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8633-2748; OpenAlex author ID A5076298207. Sources: OpenAlex.

Their work

Papers
5
Trials
0
Grants
0
Labs led
0
Collaborators
18
Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper · 2025: 2 papers · 2026: 1 paper

Papers 5

  1. Treatment landscape from first- to third-line therapy and quality of life data of patients with pancreatic cancer from the prospective German PARAGON (Platform… Co-author DOI 10.1002/ijc.70280↗
  2. Health-related quality of life and performance status with NALIRIFOX versus nab-paclitaxel + gemcitabine in treatment-naive patients with metastatic pancreatic… Co-author DOI 10.1016/j.esmoop.2025.105534↗
  3. A plain language summary of NALIRIFOX compared with nab-paclitaxel and gemcitabine for patients with metastatic pancreatic cancer (NAPOLI 3). Co-author DOI 10.1080/14796694.2025.2458458↗
  4. Adjuvant Gemcitabine Versus Neoadjuvant/Adjuvant FOLFIRINOX in Resectable Pancreatic Cancer: The Randomized Multicenter Phase II NEPAFOX Trial. Co-author DOI 10.1245/s10434-024-15011-7↗
  5. NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-lab… Co-author DOI 10.1016/s0140-6736(23)01366-1↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zev A. Wainberg · 3 shared papers, 2023–2025 · strength 0.54
  2. Sreenivasa Rao Chandana · 3 shared papers, 2023–2025 · strength 0.54
  3. Eileen Mary O'Reilly · 3 shared papers, 2023–2025 · strength 0.54
  4. Christelle de la Fouchardière · 3 shared papers, 2023–2025 · strength 0.54
  5. Andrew Scott Paulson · 3 shared papers, 2023–2025 · strength 0.54
  6. Roberto Pazo-Cid · 3 shared papers, 2023–2025 · strength 0.54
  7. Igor Kišš · 3 shared papers, 2023–2025 · strength 0.54
  8. Davide Melisi · 3 shared papers, 2023–2025 · strength 0.54
  9. Tanios Bekaii‐Saab · 3 shared papers, 2023–2025 · strength 0.54
  10. Richard A Hubner · 3 shared papers, 2023–2025 · strength 0.54
  11. Shubham Pant · 3 shared papers, 2023–2025 · strength 0.54
  12. Eric Van Cutsem · 3 shared papers, 2023–2025 · strength 0.54
  13. Teresa Mercade Macarulla · 3 shared papers, 2023–2025 · strength 0.54
  14. Salah‐Eddin Al‐Batran · 2 shared papers, 2024–2026 · strength 0.40
  15. Andrew Peter Dean · 2 shared papers, 2023–2025 · strength 0.34
  16. Ralf‐Dieter Hofheinz · 1 shared paper, 2026 · strength 0.23
  17. Marino Venerito · 1 shared paper, 2024 · strength 0.16
  18. Woo Jin Lee · 1 shared paper, 2023 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.